IUX24
TopMarketWorldEconomyFinanceTechnologyBusinessPoliticsAnalysis & Opinion

India Halts Sun Pharma Eye Drug Production

Indian drug regulators ordered Sun Pharmaceutical Industries to halt production and sales of eye care products at its Assam facility following quality management failures.

Xurve View
Insights:
A bird flies past the logo of Sun Pharmaceutical Industries Ltd., outside its corporate office in Mumbai, India, October 31, 2025. REUTERS/Francis Mascarenhas

SUN PHARMACEUTICAL INDUS halted production of ophthalmic drugs at its Assam facility after a joint federal-state inspection found quality management failures. The shutdown follows the voluntary recall of 332 batches across 11 eye-care brands.